KF
ATRS

Krilogy Financial’s Antares Pharma, Inc. ATRS Stock Holding History

Krilogy Financial’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,500
Closed -$8K – 743
2018
Q3 		$8K Buy
+2,500
New +$7.72K ﹤0.01% 566
2018
Q2 		– Sell
-2,500
Closed -$6K – 683
2018
Q1 		$6K Hold
2,500
– – ﹤0.01% 589
2017
Q4 		$5K Hold
2,500
– – ﹤0.01% 614
2017
Q3 		$8K Hold
2,500
– – ﹤0.01% 608
2017
Q2 		$8K Hold
2,500
– – ﹤0.01% 561
2017
Q1 		$6K Hold
2,500
– – ﹤0.01% 568
2016
Q4 		$6K Hold
2,500
– – ﹤0.01% 568
2016
Q3 		$4K Hold
2,500
– – ﹤0.01% 628
2016
Q2 		$3K Hold
2,500
– – ﹤0.01% 667
2016
Q1 		$2K Hold
2,500
– – ﹤0.01% 618
2015
Q4 		$3K Buy
2,500
+1,500
+150% +$2.09K ﹤0.01% 363
2015
Q3 		$11K Buy
+1,000
New +$1.96K 0.01% 383

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Krilogy Financial's ATRS Position: Q4 2018 in Review

Krilogy Financial sold out of Antares Pharma, Inc. (ATRS) in Q4 2018, closing a stake of 2,500 shares — an estimated $8K sold.

Krilogy Financial first reported a position in ATRS in Q3 2015 and held it in 12 quarters. The position peaked at $11K in Q3 2015. 120 funds tracked by Wall St. Rank hold ATRS as of Q4 2018.

  • Krilogy Financial reported no remaining Antares Pharma, Inc. position as of Q4 2018 after selling out during the quarter.
  • Krilogy Financial sold 2,500 Antares Pharma, Inc. shares in Q4 2018, an estimated $8K.
  • Krilogy Financial first reported a position in Antares Pharma, Inc. in Q3 2015 and held it in 12 quarters.
  • Krilogy Financial's Antares Pharma, Inc. position peaked at $11K in Q3 2015.
  • 120 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.